
Adverse reactions in patients undergoing luteal support as a part of ART treatment is presented in Table 2. (See Table 2.)

Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
View ADR Reporting Link